Jurgi Camblong, Director, Executive Chairman, on July 20, 2026, sold 44,381 shares in Sophia Genetics (SOPH) for $286,099. Following the Form 4 filing with the SEC, Camblong has control over a total of 3,492,822 ordinary shares of the company, with 3,492,822 shares held directly.
SEC Filing:
Anthony Mathew Eisen, Director, on July 17, 2026, sold 18,000 shares in Block (XYZ) for $1,424,040. Following the Form 4 filing with the SEC, Eisen has control over a total of 1,667,672 Class A common shares of the company, with 1,667,672 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1512673/000162828026049078/xslF345X05/wk-form4_1784670214.xml
Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs, on July 20, 2026, sold 23,054 shares in Johnson & Johnson (JNJ) for $5,792,686. Following the Form 4 filing with the SEC, Broadhurst has control over a total of 23,003 common shares of the company, with 23,003 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/200406/000020040626000148/xslF345X05/wk-form4_1784669273.xml
Russell J Weiner, Director, Chief Executive Officer, on July 17, 2026, sold 10,850 shares in Dominos Pizza (DPZ) for $3,589,506. Following the Form 4 filing with the SEC, Weiner has control over a total of 47,162 common shares of the company, with 43,829 shares held directly and 3,333 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1286681/000162245826000009/xslF345X05/ownership.xml